- PLATFORM LOGINS
- |
- CONTACT
- Request a Demo
-
NantHealth’s unified platform integrates multiple data sources so that payers and providers can proactively engage with patients and increase the quality of care, while reducing costs
According to data from the
“Value-based care holds great opportunities in improving patient outcomes while mitigating unnecessary healthcare costs, yet there are still widespread challenges to its implementation,” said
NantHealth’s new population health management tools help payers and their providers unlock meaningful data at the point of care to:
NantHealth’s population health management tools are available to all health plans including customers of Eviti Connect, a world-class evidence-based treatment intelligence platform that supports better decision making, and NaviNet Open, an industry-leading secure, multi-payer platform that elevates the payer-provider relationship from transactional to collaborative, enhancing communication and boosting operational efficiency. For more information visit, nanthealth.com/products/population-health-management.
About
Forward Looking Statement
This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to: our ability to successfully integrate a complex learning system to address a wide range of healthcare issues; our ability to successfully amass the requisite data to achieve maximum network effects; appropriately allocating financial and human resources across a broad array of product and service offerings; raising additional capital as necessary to fund our operations; achieving significant commercial market acceptance for our sequencing and molecular analysis solutions; establish relationships with, key thought leaders or payers’ key decision makers in order to establish GPS Cancer as a standard of care for patients with cancer; our ability to grow the market for our Systems Infrastructure, and applications; successfully enhancing our Systems Infrastructure and applications to achieve market acceptance and keep pace with technological developments; customer concentration; competition; security breaches; bandwidth limitations; our ability to integrate OpenNMS into our operations;; our ability to obtain regulatory approvals; dependence upon senior management; the need to comply with and meet applicable laws and regulations; unexpected adverse events; clinical adoption and market acceptance of GPS Cancer; and anticipated cost savings. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20210331005122/en/
Jen@nant.com
562-397-3630
Source: